Literature DB >> 2445659

Antigen uptake and accumulation in antigen-specific B cells.

A Lanzavecchia1.   

Abstract

Using EBV-transformed antigen-specific B-cell clones as APC, we have started to analyze the factors that govern the uptake of antigen by B cells and lead to its efficient presentation to T cells. The binding of antigen to SIg can be blocked by soluble antibodies that react with the same epitope that is seen by the B cell's SIg, but not by antibodies that bind to different epitopes. By studying the antigen presenting capacity of B cells that had been pulsed with antigen in different conditions, we came to the conclusion that specific B cells work as vacuum cleaners, i.e. over time they accumulate the antigen that binds to SIg. This effect results from the difference between the rate of influx (approximately 5-10 times the amount of antigen bound is internalized every hour by receptor-mediated endocytosis) and the rate of loss (the half-life of processed antigen relevant for T-cell activation is about 1 d). T cells specific for mouse Ig are triggered much more efficiently by mouse anti-human Ig than by mouse antibodies directed against other B-cell surface antigens, suggesting that SIg are extremely efficient for antigen internalization and processing.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445659     DOI: 10.1111/j.1600-065x.1987.tb01171.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  36 in total

Review 1.  Cellular mechanisms of antigen processing and the function of class I and II major histocompatibility complex molecules.

Authors:  C V Harding; E R Unanue
Journal:  Cell Regul       Date:  1990-06

2.  Antigen-B Cell Receptor Complexes Associate with Intracellular major histocompatibility complex (MHC) Class II Molecules.

Authors:  Margarida Barroso; Heidi Tucker; Lisa Drake; Kathleen Nichol; James R Drake
Journal:  J Biol Chem       Date:  2015-09-23       Impact factor: 5.157

Review 3.  The role of B cells in multiple sclerosis: Current and future therapies.

Authors:  Austin Negron; Rachel R Robinson; Olaf Stüve; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-10-21       Impact factor: 4.868

4.  Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies.

Authors:  Christiane Ruedl; Katrin Schwarz; Andrea Jegerlehner; Tazio Storni; Vania Manolova; Martin F Bachmann
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 5.  The role of germinal centers for antiviral B cell responses.

Authors:  M F Bachmann
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

6.  Abrogation of antibody responses in rats to murine monoclonal antibody 791T/36 by treatment with daunomycin-cis-aconityl-791T/36 conjugates.

Authors:  L G Durrant; R A Robins; R A Marksman; M C Garnett; Y Ogunmuyiwa; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Activated B cells can deliver help for the in vitro generation of antiviral cytotoxic T cells.

Authors:  Y Liu; A Müllbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

8.  Human T cell responses to beta-galactosidase.

Authors:  J D Oxley; R H Brookes; L S Rayfield; P S Shepherd
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

9.  Autopresentation of hepatitis B virus envelope antigens by T cells.

Authors:  C Ferrari; M Pilli; A Penna; A Bertoletti; A Valli; A Cavalli; G Pasetti; F Fiaccadori
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display.

Authors:  Laura K Mackay; Heather M Long; Jill M Brooks; Graham S Taylor; Carol S Leung; Adrienne Chen; Fred Wang; Alan B Rickinson
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.